Literature DB >> 19450292

Common cold.

Bruce Arroll1.   

Abstract

INTRODUCTION: Each year, children suffer up to 5 colds and adults have 2-3 infections, leading to time off school or work, and considerable discomfort. Most symptoms resolve within a week, but coughs often persist for longer. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for common cold? We searched: Medline, Embase, The Cochrane Library and other important databases up to May 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 19 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: analgesics or anti-inflammatory drugs, antibiotics, antihistamines, decongestants (norephedrine, oxymetazoline, or pseudoephedrine), decongestants plus antihistamine, echinacea, steam inhalation, vitamin C, and zinc (intranasal gel or lozenges).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19450292      PMCID: PMC2907967     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  18 in total

Review 1.  Nasal decongestants for the common cold.

Authors:  D Taverner; J Latte
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial.

Authors:  M Hirt; S Nobel; E Barron
Journal:  Ear Nose Throat J       Date:  2000-10       Impact factor: 1.697

3.  A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults.

Authors:  E A Belongia; R Berg; K Liu
Journal:  Am J Med       Date:  2001-08       Impact factor: 4.965

4.  Adverse reactions associated with echinacea: the Australian experience.

Authors:  Raymond J Mullins; Robert Heddle
Journal:  Ann Allergy Asthma Immunol       Date:  2002-01       Impact factor: 6.347

5.  Phenylpropanolamine and the risk of hemorrhagic stroke.

Authors:  W N Kernan; C M Viscoli; L M Brass; J P Broderick; T Brott; E Feldmann; L B Morgenstern; J L Wilterdink; R I Horwitz
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 91.245

6.  Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection.

Authors:  Katharine E Yoder; Michele L Shaffer; Susan J La Tournous; Ian M Paul
Journal:  Clin Pediatr (Phila)       Date:  2006-09       Impact factor: 1.168

7.  Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial.

Authors:  James A Taylor; Wendy Weber; Leanna Standish; Hal Quinn; Jenna Goesling; Mary McGann; Carlo Calabrese
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

8.  Is there a common cold constitution?

Authors:  Thomas M Ball; Catharine J Holberg; Fernando D Martinez; Anne L Wright
Journal:  Ambul Pediatr       Date:  2002 Jul-Aug

9.  Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults.

Authors:  S B Mossad
Journal:  QJM       Date:  2003-01

Review 10.  Efficacy of zinc against common cold viruses: an overview.

Authors:  Darrell Hulisz
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Sep-Oct
View more
  1 in total

1.  Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019.

Authors:  Xuting Jin; Jiajia Ren; Ruohan Li; Ya Gao; Haoying Zhang; Jiamei Li; Jingjing Zhang; Xiaochuang Wang; Gang Wang
Journal:  EClinicalMedicine       Date:  2021-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.